Table 1 Commonly deregulated and predicted gene targets of miR-21-5p in three different patient data sets
From: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities
Gene | n softw pred. | Gastric mRNA | Head/neck miRNA/mRNA | TGCA breast miRNA/mRNA | Combined P-value | Combined P-value Stouffer | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P-value T/N | FDR | Log2fold T/N | R Pearson | P-value Pearson | P-value T/N | FDR | Log2fold T/N | R Pearson | P-value Pearson | P-value T/N | FDR | Log2fold T/N | ||||
CAB39L | 5 | 0.0001152 | 0.0019075 | −1.4499698 | −0.760 | 1.133E-06 | 1.188E-05 | 0.002008 | −2.026 | −0.226 | 7.82E-08 | 1.92E-05 | 2.31E-05 | −0.8002 | 3.859E-35 | 0 |
SESN1 | 4 | 0.0051602 | 0.0172594 | −0.9251614 | −0.401 | 0.0280352 | 0.0020789 | 0.0449665 | −0.877 | −0.312 | 5.68E-14 | 0.048219 | 0.0151231 | −1.1244375 | 4.821E-20 | 0 |
CDH19 | 5 | 0.0025804 | 0.0110663 | −0.9266954 | −0.669 | 5.281E-05 | 0.0046097 | 0.0723101 | −0.723 | −0.187 | 8.99E-06 | 0.0044263 | 0.0019835 | −1.7027083 | 2.646E-18 | 5.551E-17 |
PLP1 | 4 | 7.931E-05 | 0.0016367 | −1.2054348 | −0.729 | 4.952E-06 | 4.833E-06 | 0.0014273 | −1.150 | −0.284 | 9.99E-12 | 0.0451993 | 0.0143104 | −1.504125 | 3.314E-17 | 5.551E-17 |
SCP2 | 4 | 0.001315 | 0.0073171 | −0.7303324 | −0.427 | 0.018561 | 0.0009213 | 0.0265006 | −0.573 | −0.311 | 6.58E-14 | 0.0046633 | 0.0020689 | −0.6649583 | 4.757E-16 | 5.211E-13 |
GREM2 | 5 | 6.857E-06 | 0.0010567 | −2.0507565 | −0.399 | 0.0288326 | 3.02E-05 | 0.0033958 | −1.263 | −0.178 | 2.59E-05 | 0.0325748 | 0.0108243 | −1.7469698 | 2.162E-14 | 1.155E-11 |
CNTFR | 6 | 0.0064167 | 0.019916 | −0.6214109 | −0.492 | 0.0057344 | 0.0053505 | 0.0785863 | −0.418 | −0.366 | 5.04E-19 | 2.96E-07 | 1.94E-06 | −0.656 | 2.474E-13 | 8.092E-12 |
SLC16A7 | 3 | 1.304E-06 | 0.0009245 | −3.042192 | −0.592 | 0.0005743 | 4.05E-06 | 0.0012815 | −1.316 | −0.415 | 1.43E-24 | 0.030846 | 0.0103129 | −2.09625 | 4.504E-13 | 1.82E-12 |